Table 3 Clinical outcomes
Clinical outcomes | Values |
|---|---|
Treatment success, n, % | 27 (90) |
Surgical referral, n, % | 0 (0) |
Survival upon hospital discharge, n, % | 30 (100) |
Mortality at 30 days, n, % | 3 (10) |
Median length of hospital stay, days (IQR) | 17 (11.7–24.2) |
Median length of stay from first dose intrapleural therapy, days (IQR) | 8 (4.8–12) |
Median duration of intercostal catheter in pleural cavity, days (IQR) | 10 (8–14.3) |
Median duration of intercostal catheter in pleural cavity post first dose intrapleural therapy, days (IQR) | 6 (4–7.3) |
Received ≤ 2 doses intrapleural therapy, median (%) | 8 (26.7) |
Adverse eventsx, n, % | |
|---|---|
Chest pain requiring escalation of analgesics | 6 (20) |
Gastrointestinal bleed | 1 (3.3) |
Clinical deterioration | 1 (3.3) |
Hemoptysis | 1 (3.3) |